Novartis Ag (NVSEF) Free Cash Flow Growth (5y) (2014 - 2026)

Novartis Ag (NVSEF) Free Cash Flow Growth (5y) (2014 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Novartis Ag - - -

Historic Data

Download Data
DateValue
Mar 31, 2026 7.06%
Dec 31, 2025 -38.65%
Sep 30, 2025 4.88%
Jun 30, 2025 10.75%
Mar 31, 2025 1.40%
Dec 31, 2024 75.60%
Sep 30, 2024 -2.10%
Jun 30, 2024 79.06%
Mar 31, 2024 -4.25%
Dec 31, 2023 73.29%
Sep 30, 2023 -2.42%
Jun 30, 2023 -1.97%
Mar 31, 2023 -8.22%
Dec 31, 2022 55.01%
Sep 30, 2022 -10.37%
Jun 30, 2022 0.50%
Mar 31, 2022 -5.66%
Dec 31, 2021 62.90%
Sep 30, 2021 -4.55%
Jun 30, 2021 58.30%